Confocal endomicroscopy (CEM) improves efficiency of Barrett surveillance
- PMID: 23687587
- PMCID: PMC3655342
- DOI: 10.4161/jig.22175
Confocal endomicroscopy (CEM) improves efficiency of Barrett surveillance
Abstract
Background: Endoscopists with extensive experience with confocal endomicroscopy (CEM) have demonstrated that this technology is useful for Barrett's esophagus (BE) surveillance. However, data on endoscopists with minimal experience with this technique are limited.
Hypothesis: For BE surveillance, an endoscopist with minimal experience in CEM-guided biopsy would achieve a similar diagnostic yield with fewer biopsies when compared to the random 4-quadrant biopsy protocol.
Objective: To compare the diagnostic yields of CEM-guided biopsy technique with the random 4-quadrant biopsy protocol.
Design: Randomized controlled trial.
Setting: Tertiary care center.
Patients: Patients with BE.
Methods: Out of 18 patients who underwent routine BE surveillance, 11 and 7 were randomly assigned to group A (CEM-guided) and to group B (random 4-quadrant biopsy), respectively. The pathologists were blinded to all clinical information.
Results: Mean length of endoscopic Barrett was similar in both groups, (5.1 vs. 6.3 cm, p=0.51). The diagnostic yields for detecting SIM (63.6% vs. 59.5%, p=0.5), low grade dysplasia (11. 6% vs. 11.2%, p=NS), high grade dysplasia (10.1% vs. 11.5%, p=0.88). Although the total number of individual mucosal biopsy performed were 52% lower in the CEM group (129 vs. 269), the overall diagnostic yield (85.3% vs. 82.2%, p=0.53) was similar in both groups.
Limitations: Small sample size.
Conclusions: For BE surveillance, limited data suggested that endoscopists with minimal experience in CEM can effective use this technology for "smart" biopsy to decrease the need for intense tissue sampling but without lowering the diagnostic yield in detecting dysplasia.
Keywords: Barrett's esophagus; confocal endomicroscopy.
Figures
References
-
- Spechler SJ. Clinical practice. Barrett's Esophagus. N Engl J Med. 2002;346:836–842. - PubMed
-
- Shaheen NJ. Advances in Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology. 2005;128:1554–1566. - PubMed
-
- Sampliner RE. Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol. 2002;97:1888–1895. - PubMed
-
- Wo JM, Ray MB, Mayfield-Stokes S, Al-Sabbagh G, Gebrail F, Slone SP, et al. Comparison of methylene blue-directed biopsies and conventional biopsies in the detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a preliminary study. Gastrointest Endosc. 2001;54:294–301. - PubMed
-
- Ragunath K, Krasner N, Raman VS, Haqqani MT, Cheung WY. A randomized, prospective cross-over trial comparing methylene blue-directed biopsy and conventional random biopsy for detecting intestinal metaplasia and dysplasia in Barrett's esophagus. Endoscopy. 2003;35:998–1003. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous